Product Information

LACOSAMIDE 200 MG/20 ML CUP is a generic product labeled by PAI Holdings LLC, priced at $0.0820 per ML under NDC 00121404895. Its NADAC has been published 149 times since Oct 18, 2023.

FDA first approved this application on Aug 26, 2022. Its Orange Book therapeutic-equivalence code is AA.

The Low Outlier badge above means this manufacturer's average price in the Lacosamide market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LACOSAMIDE 200 MG/20 ML CUP

Lacosamide
$0.0820per ML
Low Outlier
DEA Schedule CV

Strength

200 mg/20mL

Manufacturer

PAI Holdings LLC

NDC

00121404895

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LACOSAMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA216151

FDA Approved

8/26/2022

TE Code

AA

On Market Since

8/26/2022

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for LACOSAMIDE 200 MG/20 ML CUP has been published 149 times since Oct 18, 2023, and over the history we have for it it has declined 31.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0820 per ML
All-time high$0.1475 (Apr 10, 2024)
All-time low$0.0820 (Aug 19, 2026)
52-week high$0.1070
52-week low$0.0820
Median price$0.1072
Average price$0.1116
Largest weekly change+32.8% (Jun 19, 2024)
Weeks tracked149
Tracking sinceOct 18, 2023

Price History

1W

-2.0%

1M

-2.0%

3M

-7.9%

6M

-14.0%

1Y

-22.9%

3Y

N/A

5Y

N/A

All

-31.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Lacosamide market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of LACOSAMIDE 200 MG/20 ML CUP?

The current National Average Drug Acquisition Cost (NADAC) for LACOSAMIDE 200 MG/20 ML CUP, manufactured by PAI Holdings LLC, is $0.0820 per ML (NDC 00121404895), effective Aug 19, 2026.

How has the price of LACOSAMIDE 200 MG/20 ML CUP changed over time?

Over the history we have for it, the NADAC for LACOSAMIDE 200 MG/20 ML CUP has declined 31.2%. It has been tracked across 149 weekly CMS publications since Oct 18, 2023.

What are the highest and lowest recorded NADAC prices for LACOSAMIDE 200 MG/20 ML CUP?

Since Oct 18, 2023, the NADAC for LACOSAMIDE 200 MG/20 ML CUP has ranged from a low of $0.0820 (Aug 19, 2026) to a high of $0.1475 (Apr 10, 2024), with a median of $0.1072 per ML.

Are there cheaper alternatives to LACOSAMIDE 200 MG/20 ML CUP?

No other NADAC-published product currently shares the active ingredient and strength of LACOSAMIDE 200 MG/20 ML CUP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures LACOSAMIDE 200 MG/20 ML CUP?

LACOSAMIDE 200 MG/20 ML CUP (NDC 00121404895) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.